<?xml version="1.0"?>
<rss version="2.0">
<channel>
<title>Healthcare Industry Today: PSA Screening News</title>
<link>http://health.einnews.com/news/psa-testing</link><description>Constantly updated news and information about healthcare industry.</description><item>
<title>In Patients Experiencing Biochemical Failure After Radiotherapy, Pretreatment Risk Group and PSA Velocity Predict Differences in Overall Survival and Biochemical Failure-Free Interval</title>
<link>http://health.einnews.com/news.php?wid=170180592</link>
<pubDate>16 May 2008 08:17 GMT</pubDate>
<description>
...  Bologna, S. Orsola-Malpighi Hospital, Italy. Epidemiology Program, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington. Department of Surgery, Division of Urology, Kuwait University, Kuwait. Cancer  ...
</description>
</item><item>
<title>Changes in Baseline PSA Levels in Japanese Men From 1988 to 2003</title>
<link>http://health.einnews.com/news.php?wid=170180589</link>
<pubDate>16 May 2008 08:17 GMT</pubDate>
<description>
...  epidemiologic surveys, the number of deaths from prostate cancer in Japanese men increased rapidly from 1970  ...  we hypothesized that changes in the baseline PSA distribution in the screening population could reflect  ...
</description>
</item><item>
<title>PSA and Follow-Up after Treatment of Prostate Cancer</title>
<link>http://health.einnews.com/news.php?wid=170180587</link>
<pubDate>16 May 2008 08:17 GMT</pubDate>
<description>
...  Lille cedex, France. A first serum total PSA assay is recommended during the first three  ...  time (PSADT). In the absence of residual cancer, PSA becomes undetectable by the first month after total prostatectomy: less than 0.1ng/ml (or less than 0.07ng/ml)  ...
</description>
</item><item>
<title>Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting</title>
<link>http://health.einnews.com/news.php?wid=170163000</link>
<pubDate>16 May 2008 05:57 GMT</pubDate>
<description>
...  MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology  ...  include safety, tolerability, pharmacokinetics, effects on serum PSA levels and disease progression. Medivation expects to  ...
</description>
</item><item>
<title>Low cholesterol leads to lower prostate- specific antigen levels</title>
<link>http://health.einnews.com/news.php?wid=170151109</link>
<pubDate>16 May 2008 04:52 GMT</pubDate>
<description>
... Low cholesterol leads to lower prostate- specific antigen levels May 15th, 2008 -  ...  relationship between low-density lipoprotein (LDL) cholesterol and PSA prior to beginning statin therapy. Data collected  ...  cholesterol may play a role in prostate cancer development and progression. Data was collected from  ...
</description>
</item><item>
<title>Gentlemen, assume the position</title>
<link>http://health.einnews.com/news.php?wid=170146246</link>
<pubDate>16 May 2008 04:47 GMT</pubDate>
<description>
...  9:43 AM EDT After being diagnosed with prostate cancer, Richard Bercuson visited the Ottawa Regional Cancer  ...  pathology reports that read simply &quot;stage T2a, PSA 6.06, Gleason 6/10&quot; and to graduate magna  ...
</description>
</item><item>
<title>Genes Play Part in Prostate Cancer Among Races</title>
<link>http://health.einnews.com/news.php?wid=170142880</link>
<pubDate>16 May 2008 03:19 GMT</pubDate>
<description>
...  explain why white men have a higher prostate cancer risk than Hispanic men, information which may  ...  cancer risk is the prostate specific antigen (PSA) test. But the test can identify tumors  ...
</description>
</item><item>
<title>Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th</title>
<link>http://health.einnews.com/news.php?wid=170137958</link>
<pubDate>16 May 2008 02:15 GMT</pubDate>
<description>
...  MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology  ...  include safety, tolerability, pharmacokinetics, effects on serum PSA levels and disease progression. Medivation expects to  ...
</description>
</item><item>
<title>Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Pro</title>
<link>http://health.einnews.com/news.php?wid=170136262</link>
<pubDate>16 May 2008 02:02 GMT</pubDate>
<description>
...  MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology  ...  include safety, tolerability, pharmacokinetics, effects on serum PSA levels and disease progression. Medivation expects to  ...
</description>
</item><item>
<title>Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting</title>
<link>http://health.einnews.com/news.php?wid=170134622</link>
<pubDate>16 May 2008 01:35 GMT</pubDate>
<description>
...  title: New Targeted Strategies for Patients with Prostate Cancer Session date and time: Monday, June 2  ...  include safety, tolerability, pharmacokinetics, effects on serum PSA levels and disease progression. Medivation expects to  ...
</description>
</item><item>
<title>Genes Play Part in Prostate Cancer Among Races</title>
<link>http://health.einnews.com/news.php?wid=170081604</link>
<pubDate>15 May 2008 18:36 GMT</pubDate>
<description>
... Genes Play Part in Prostate Cancer Among Races Whites at higher risk than  ...  cancer risk is the prostate specific antigen (PSA) test. But the test can identify tumors  ...
</description>
</item><item>
<title>Vaccine Provides Help For Prostate Cancer Patients</title>
<link>http://health.einnews.com/news.php?wid=170058860</link>
<pubDate>15 May 2008 15:59 GMT</pubDate>
<description>
... Vaccine Provides Help For Prostate Cancer Patients Posted on: Thursday, 15 May 2008,  ...  University of Iowa presented data on the adenovirus/PSA (Ad/PSA) vaccine today during the Annual Scientific  ...
</description>
</item><item>
<title>Lowering Cholesterol Lowers PSA Levels</title>
<link>http://health.einnews.com/news.php?wid=170049843</link>
<pubDate>15 May 2008 14:54 GMT</pubDate>
<description>
...  cholesterol may also help you manage your prostate- specific antigen (PSA) level. Data presented today  ...  relationship between low-density lipoprotein (LDL) cholesterol and PSA prior to beginning statin therapy. Data collected  ...  cholesterol may play a role in prostate cancer development and progression. Data was collected from  ...
</description>
</item><item>
<title>Therapeutic Vaccine Prolongs Survival And Improves Quality Of Life</title>
<link>http://health.einnews.com/news.php?wid=170046406</link>
<pubDate>15 May 2008 14:50 GMT</pubDate>
<description>
...  the concept of vaccine immunotherapy for advanced prostate cancer has become increasingly high profile as research  ...  these cancer cells throughout the body. The Ad/PSA vaccine was developed by inserting the PSA  ...
</description>
</item><item>
<title>Race, Family History Or Baseline PSA: Which Best Predicts Prostate Cancer Risk?</title>
<link>http://health.einnews.com/news.php?wid=170046404</link>
<pubDate>15 May 2008 14:50 GMT</pubDate>
<description>
...  (AUA) in Orlando, African-American men with known prostate cancer risk factors with baseline levels higher than  ...  to develop prostate cancer if their baseline PSA level was below the age-specific median. The  ...
</description>
</item></channel>
</rss>
